225 related articles for article (PubMed ID: 10370187)
41. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
[TBL] [Abstract][Full Text] [Related]
42. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.
Raimondi AC; Schottlender J; Lombardi D; Molfino NA
Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352
[TBL] [Abstract][Full Text] [Related]
43. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
[TBL] [Abstract][Full Text] [Related]
44. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler.
Robertson CF; Norden MA; Fitzgerald DA; Connor FL; Van Asperen PP; Cooper PJ; Francis PW; Allen HD
J Paediatr Child Health; 1998 Apr; 34(2):142-6. PubMed ID: 9588637
[TBL] [Abstract][Full Text] [Related]
45. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
[TBL] [Abstract][Full Text] [Related]
46. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ; Senn S; Mezzanotte WS
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[TBL] [Abstract][Full Text] [Related]
47. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
[TBL] [Abstract][Full Text] [Related]
48. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
49. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
[TBL] [Abstract][Full Text] [Related]
50. Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode.
Drblik S; Lapierre G; Thivierge R; Turgeon J; Gaudreault P; Cummins-McManus B; Verdy I; Haddon J; Lee J; Spier S
Arch Dis Child; 2003 Apr; 88(4):319-23. PubMed ID: 12651757
[TBL] [Abstract][Full Text] [Related]
51. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
[TBL] [Abstract][Full Text] [Related]
53. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack.
Nana A; Youngchaiyud P; Charoenratanakul S; Boe J; Löfdahl CG; Selroos O; Ståhl E
J Asthma; 1998; 35(8):647-55. PubMed ID: 9860085
[TBL] [Abstract][Full Text] [Related]
54. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma.
Pohunek P; Matulka M; Rybnícek O; Kopriva F; Honomichlová H; Svobodová T
Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380
[TBL] [Abstract][Full Text] [Related]
55. Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma.
Blake K; Madabushi R; Derendorf H; Lima J
Chest; 2008 Nov; 134(5):981-989. PubMed ID: 18583517
[TBL] [Abstract][Full Text] [Related]
56. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
57. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.
Rodrigo C; Rodrigo G
Am J Emerg Med; 1998 Nov; 16(7):637-42. PubMed ID: 9827736
[TBL] [Abstract][Full Text] [Related]
58. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C
Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653
[TBL] [Abstract][Full Text] [Related]
59. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
60. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
